Provenienza dei contatti di primo grado di Brian Hodous
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Brian Hodous tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Halda Therapeutics LLC
 Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
Jamanda Ltd.
 Jamanda Ltd. Financial ConglomeratesFinance Jamanda Ltd. is an investment holding British company founded in 2016. The private company is based in Grantham, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Director/Board Member | |
| ARVINAS, INC. | Biotechnology | Director/Board Member | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member | |
| APTINYX | Pharmaceuticals: Major | Director/Board Member | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Halda Therapeutics OpCo, Inc. | Director/Board Member | ||
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avenzo Therapeutics, Inc. is a biotechnology company that operates in the field of therapeutics. The company is based in San Diego, CA. The company was founded by Mohammad Hirmand and the CEO is Athena M. Countouriotis. | Miscellaneous Commercial Services | Chief Executive Officer | |
| CARIBOU BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| University of British Columbia | College/University | Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Public Communications Contact | |
| Middlebury College | College/University | Undergraduate Degree | |
Eurofins DiscoverX Corp., Inc.
 Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Leal Therapeutics, Inc. develops novel therapeutics for patients with major disorders of the central nervous systems. | Miscellaneous Commercial Services | Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chairman | |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Access Industries LLC | Corporate Officer/Principal | ||
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Regno Unito | 7 |
| Canada | 2 |
Settori
| Health Technology | 37 |
| Commercial Services | 6 |
| Consumer Services | 6 |
| Health Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 62 |
| Independent Dir/Board Member | 24 |
| Corporate Officer/Principal | 12 |
| Chief Tech/Sci/R&D Officer | 9 |
| Chairman | 7 |
Contatti più connessi
- Borsa valori
- Insiders
- Brian Hodous
- Connessioni Società
